No cases of the variant, which was first reported to the World Health Organisation (WHO) from South Africa on November 24, have been recorded in India
The company has also developed an antibody cocktail which can be used both to prevent and to treat Covid-19
The country launched vaccination for all people aged more than 45 years from April 1
The remaining 58 million were supplied by the Serum Institute of India under its commercial and COVAX obligations
Russian Direct Investment Fund has Serum Institute as its production partner in India
The next phase of Covid-19 vaccination commenced from March 1 for people over 60 years of age and those aged 45 and above with specified comorbid conditions
Firm expanding mRNA lipids capacity 10-fold, overall plant capacity by 6 times by June
The next phase of Covid-19 vaccination commenced from March 1 for people over 60 years of age and those aged 45 and above with specified co-morbid conditions
The country launched vaccination for all people aged above 45 years from April 1
Earlier this month, the Bharat Biotech manufactured Covaxin had received its WHO EUL status
WHO setting up Global Centre for traditional medicines in India
Single-window system to take care of regulatory need for drugs, vaccines
India must speed up vaccination
JAB AT HAND: From encouraging people to volunteer to screening kids and winning their confidence
Becomes sixth vaccine to receive validation; move will ease foreign travel for those who got jab
Covaxin gets the stamp of international legitimacy
The central government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country, the ministry said.
More than 58 lakh (58,87,981) vaccine doses have been administered till 7 pm on Monday
Firm plans to make a billion annual doses of the vaccine apart from 600 million J&J doses a year
The one-billion mark for vaccines has given a ray of hope for small businesses, hawkers and vendors, Modi said